Precision Medicines for CNS and Rare Diseases

Caraway Therapeutics is an emerging biopharmaceutical company pursuing novel approaches for the treatment of debilitating neurodegenerative and rare diseases diseases by enhancing cellular clearance. It is a leader in developing therapeutics that activate the lysosome, the cell’s recycling center, to clear toxic materials and defective cellular components.  Caraway has a rigorous, scientific product engine with multiple approaches, using genetically defined targets to find potential treatments related to these processes.